We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$258M
AUM Growth
-$3.31M
Cap. Flow
+$3.66M
Cap. Flow %
1.42%
Top 10 Hldgs %
68%
Holding
56
New
1
Increased
26
Reduced
11
Closed
2

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$927K
2
PANW icon
Palo Alto Networks
PANW
+$522K
3
MSFT icon
Microsoft
MSFT
+$501K
4
AMZN icon
Amazon
AMZN
+$470K
5
FIVE icon
Five Below
FIVE
+$464K

Sector Composition

Rank Sector Weight
1 Technology 37.42%
2 Consumer Discretionary 28.28%
3 Healthcare 21.48%
4 Communication Services 9.88%
5 Utilities 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$162B
$2.24M 0.87%
36,346
-1,254
-3% -$79.1K
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$1.99M 0.77%
27,947
+2,885
+12% +$209K
AMD icon
28
Advanced Micro Devices
AMD
$807B
$1.91M 0.74%
30,180
+10,892
+56% +$927K
PFE icon
29
Pfizer
PFE
$141B
$903K 0.35%
20,630
+1,450
+8% +$70.5K
CTSH icon
30
Cognizant
CTSH
$22.3B
$902K 0.35%
15,711
-3,187
-17% -$209K
JNJ icon
31
Johnson & Johnson
JNJ
$641B
$900K 0.35%
5,507
+400
+8% +$67.7K
COST icon
32
Costco
COST
$422B
$889K 0.34%
1,883
ABT icon
33
Abbott
ABT
$182B
$869K 0.34%
8,986
+280
+3% +$29.8K
BCRX icon
34
BioCryst Pharmaceuticals
BCRX
$2.43B
$864K 0.33%
68,600
PAYX icon
35
Paychex
PAYX
$41.1B
$802K 0.31%
7,150
-100
-1% -$12.4K
NSC icon
36
Norfolk Southern
NSC
$77.1B
$742K 0.29%
3,541
+100
+3% +$24K
MRK icon
37
Merck
MRK
$323B
$740K 0.29%
8,592
+880
+11% +$78.6K
DE icon
38
Deere & Co
DE
$169B
$521K 0.2%
1,561
PANW icon
39
Palo Alto Networks
PANW
$259B
$494K 0.19%
+6,030
New +$522K
NUE icon
40
Nucor
NUE
$56.4B
$448K 0.17%
4,190
-25
-0.6% -$3.14K
JPM icon
41
JPMorgan Chase
JPM
$947B
$432K 0.17%
4,134
BA icon
42
Boeing
BA
$167B
$356K 0.14%
2,940
URGN icon
43
UroGen Pharma
URGN
$2.02B
$342K 0.13%
41,131
TGT icon
44
Target
TGT
$63.7B
$309K 0.12%
2,080
-20
-1% -$3.2K
CAT icon
45
Caterpillar
CAT
$402B
$265K 0.1%
1,617
DUK icon
46
Duke Energy
DUK
$100B
$244K 0.09%
2,626
TROW icon
47
T. Rowe Price
TROW
$25.5B
$224K 0.09%
2,135
EOLS icon
48
Evolus
EOLS
$407M
$202K 0.08%
25,070
BBIG
49
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$74K 0.03%
4,000
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
$60K 0.02%
50,000

Similar funds

Bender Robert & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Bender Robert & Associates held 56 positions worth $258M, down 1.3% from $262M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bender Robert & Associates's Q3 2022 filing shows 1 new, 26 increased, 11 reduced and 2 closed positions. Its largest new stake was Palo Alto Networks: 6,030 shares worth $494K. The largest sale was VMware, Inc, an estimated $965K.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q3 2022 buy was Palo Alto Networks: 6,030 shares worth $494K.
  • Bender Robert & Associates added most to Advanced Micro Devices in Q3 2022, an estimated $927K increase.
  • Bender Robert & Associates's biggest Q3 2022 reduction was VMware, Inc, cutting an estimated $965K.
  • Bender Robert & Associates fully exited Visa in Q3 2022, selling an estimated $221K.
  • Bender Robert & Associates's ten largest holdings make up 68% of its $258M portfolio in Q3 2022.
  • Bender Robert & Associates opened 1 new position and closed 2 in Q3 2022.
  • Bender Robert & Associates's portfolio value fell 1.3% quarter-over-quarter to $258M.

Based on Bender Robert & Associates's 13F filing for Q3 2022, filed 27 Oct 2022.